| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |